Our previous analysis of SNVs and rare patient-specific single nucleotide polymorphisms in MM patients demonstrated that IGF1R is one of the most frequently affected RTK genes and that RTK mutations are associated with inferior survival [26,27], supporting the role of IGF1R as a bad prognostic marker in MM [28]. This evidence concerns the gene IGF1R and Miyoshi myopathy.